CURTANA PHARMACEUTICALS INC has a total of 26 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GUANGZHOU BEBETTER MEDICINE TECH CO LTD, MERCK SHARPE & DOHME LTD and LUNDBECK LA JOLLA RESEARCH CENTER INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | Singapore | 2 | |
#11 | Hong Kong | 1 | |
#12 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Beaton Graham | 21 |
#2 | Campos Bismarck | 20 |
#3 | Mchardy Stanton F | 20 |
#4 | Wang Hua-Yu Leo | 16 |
#5 | Lopez Ambrosio Jr | 12 |
#6 | Ravula Satheesh B | 11 |
#7 | Tucci Fabio C | 10 |
#8 | Ruiz Francisco Xavier Iii | 8 |
#9 | Lopez Jr Ambrosio | 5 |
#10 | Graham Beaton | 4 |
Publication | Filing date | Title |
---|---|---|
WO2019169112A1 | Inhibition of olig2 activity | |
BR112019003973A2 | olig2 activity inhibition | |
KR20170129785A | Inhibition of OLIG2 activity | |
US2016237069A1 | Inhibition of OLIG2 activity |